Adicet Bio (ACET) has released an update.
On January 22, 2024, the Company announced the pricing of an Offering through a press release. The Company had $159.7 million in cash and equivalents as of December 31, 2023. It sold 6,350,000 shares at an average price of $3.13 per share since September 30, 2023, under the Capital On Demand™ Sales Agreement with JonesTrading Institutional Services, LLC, yielding about $19.3 million in net proceeds after commissions and before other expenses.
For further insights into ACET stock, check out TipRanks’ Stock Analysis page.
